Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 83
2021 3
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 33408097

85 results
Results by year
Filters applied: . Clear all
Page 1
Remdesivir for patients with COVID-19.
Wu PE, Morris AM. Wu PE, et al. CMAJ. 2021 Jan 6:cmaj.202505. doi: 10.1503/cmaj.202505. Online ahead of print. CMAJ. 2021. PMID: 33408097 Free article. No abstract available.
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
Davies M, Osborne V, Lane S, Roy D, Dhanda S, Evans A, Shakir S. Davies M, et al. Drug Saf. 2020 Jul;43(7):645-656. doi: 10.1007/s40264-020-00952-1. Drug Saf. 2020. PMID: 32468196 Free PMC article.
Remdesivir, a remedy or a ripple in severe COVID-19?
Doggrell SA. Doggrell SA. Expert Opin Investig Drugs. 2020 Nov;29(11):1195-1198. doi: 10.1080/13543784.2020.1821645. Epub 2020 Sep 20. Expert Opin Investig Drugs. 2020. PMID: 32896184 Free PMC article.
Remdesivir for the treatment of COVID-19: a living systematic review.
Verdugo-Paiva F, Acuña MP, Solá I, Rada G; COVID-19 L·OVE Working Group. Verdugo-Paiva F, et al. Medwave. 2020 Dec 9;20(11):e8080. doi: 10.5867/medwave.2020.11.8080. Medwave. 2020. PMID: 33361753 English.
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies.
Singh AK, Singh A, Singh R, Misra A. Singh AK, et al. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):641-648. doi: 10.1016/j.dsx.2020.05.018. Epub 2020 May 12. Diabetes Metab Syndr. 2020. PMID: 32428865 Free PMC article. Review.
Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
Sun D. Sun D. AAPS J. 2020 May 26;22(4):77. doi: 10.1208/s12248-020-00459-8. AAPS J. 2020. PMID: 32458279 Free PMC article.
Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.
Nili A, Farbod A, Neishabouri A, Mozafarihashjin M, Tavakolpour S, Mahmoudi H. Nili A, et al. Rev Med Virol. 2020 Nov;30(6):1-13. doi: 10.1002/rmv.2133. Epub 2020 Jul 30. Rev Med Virol. 2020. PMID: 33210457 Review.
A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.
Hashemian SM, Farhadi T, Velayati AA. Hashemian SM, et al. Drug Des Devel Ther. 2020 Aug 6;14:3215-3222. doi: 10.2147/DDDT.S261154. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32821086 Free PMC article. Review.
Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis.
Elsawah HK, Elsokary MA, Abdallah MS, ElShafie AH. Elsawah HK, et al. Rev Med Virol. 2020 Oct 31:e2187. doi: 10.1002/rmv.2187. Online ahead of print. Rev Med Virol. 2020. PMID: 33128490 Review.
The journey of remdesivir: from Ebola to COVID-19.
Pardo J, Shukla AM, Chamarthi G, Gupte A. Pardo J, et al. Drugs Context. 2020 May 22;9:2020-4-14. doi: 10.7573/dic.2020-4-14. eCollection 2020. Drugs Context. 2020. PMID: 32547625 Free PMC article. Review.
85 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page